When was Biolinq founded?

Biolinq was founded in 2012 and raised its 1st funding round 2 years after it was founded.

Where is Biolinq located?

Biolinq is headquartered in San Diego, United States.

How many employees does Biolinq have?

As of Aug 31, 2026, the latest employee count at Biolinq is 138.

Is Biolinq a funded company?

Biolinq is a funded company, having raised a total of $280M across 16 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jan 01, 2014.

How much is Biolinq worth?

The latest valuation of Biolinq is $***** as of Apr 01, 2025.

When was the latest funding round of Biolinq?

Biolinq's latest funding was a $***** Grant (prize money) round on Jun 12, 2025, with participation from 1 investor.

Where does Biolinq rank among its competitors?

Biolinq ranks 11th amongst 307 active competitors, of which 78 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Signos, which secured $20M in May, 2026.

Who are the top competitors of Biolinq?

Biolinq's top competitors include Dexcom, Insulet and Senseonics. Among them, Signos secured the most recent funding round in May, 2026.

Biolinq - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of a wearable biosensor platform for diabetes monitoring. It offers a wireless microsensor that enables users to understand their metabolism and blood glucose levels in real-time.

Key Metrics

Founded Year

2012

Location

San Diego, United States

Stage

Series C

Total Funding

$280M in 16 rounds

Latest Funding Round

Grant (prize money), Jun 12, 2025, $*****

Post Money Valuation

$***** as on Apr 01, 2025

Investors

Alpha Wave Global & 29 more

Ranked

11^th among 307 active competitors

Employee Count

138 as on Aug 31, 2026

Similar Companies

Dexcom & 442 more

View Biolinq's full profile

Biolinq has raised a total funding of $280M over 16 rounds. Its first funding round was on Jan 01, 2014. Its latest funding round was a Grant (prize money) round on Jun 12, 2025 for $*****. 1 investor participated in its latest round. Biolinq has 30 institutional investors.

Here is the list of recent funding rounds of Biolinq:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 12, 2025	9627481	Grant (prize money)	9113474	3424130	5749248	1003704
Mar 07, 2025	8977139	Series C	6268516	5646643	8713585	RiverVest Venture Partners & 6 more
Dec 13, 2023	7918317	Series B	9688807	6842250	Alpha Wave Global	Niterra & 7 more

Access funding benchmarks and valuations. Sign up today!

View details of Biolinq's funding rounds and investors

Biolinq's employee count trend

Biolinq has 138 employees as of Aug 26. Here is Biolinq's employee count trend over the years:

Uncover Biolinq's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Biolinq include Dexcom, Insulet and Senseonics. Here is the list of Top 10 competitors of Biolinq, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Dexcom 1999, San Diego (United States), Public	Provider of a wearable device for glucose monitoring	$52.7M	Invesco Mutual Fund, Canaan & 7 others	79/100
2nd	Insulet 2000, Boston (United States), Public	Manufacturer of wearable, tubeless insulin delivery systems for diabetes management	$120M	Federated Hermes, Piper Jaffray & 13 others	74/100
3rd	Senseonics 1996, Germantown (United States), Public	Provider of implantable systems for continuous glucose monitoring	$165M	Greenspring Associates, Vensana Capital & 9 others	71/100
4th	Signos 2020, San Francisco (United States), Series B	Provider of a wearable device for blood glucose pattern monitoring	$57M	Google Ventures, Cheyenne Ventures & 14 others	71/100
5th	mySugr 2012, Vienna (Austria), Acquired	Gamification apps for diabetes management and therapy	$4.8M	iSeed Ventures, Roche & 7 others	70/100
6th	Levels 2019, United States, Series A	Provider of wearable device for personalized insights into metabolic health	$67M	TriplePoint Capital, Trust Ventures & 36 others	70/100
7th	Livongo 2014, San Francisco (United States), Acquired	Provider of smart devices for diabetes management for patients and doctors	$245M	General Catalyst, Kinnevik & 21 others	69/100
8th	sugar.fit 2021, Bengaluru (India), Series A	Provider of diabetes care and reversal programs	$26.7M	B Capital, MassMutual Ventures & 17 others	68/100
9th	Jana Care 2011, Newton (United States), Series C	Provider of mobile-based healthcare diagnostics for diabetes prevention	$35.7M	IAG Capital Partners, MK Energy & 16 others	63/100
10th	LIOM 2017, Pfaffikon (Switzerland), Series A	LIOM is a Swiss deep-tech company building the ultimate health wearable for conscious living – a continuous, needle-free window into your body's chemistry, starting with glucose	$79.3M	Ornament, Daniel Gutenberg & 11 others	63/100
11th	Biolinq 2012, San Diego (United States), Series C	Provider of a wearable biosensor platform for diabetes monitoring	$280M	BioBrit, RiverVest Venture Partners & 28 others	58/100